معرفی
François-Xavier Lacasse is a tenured Professor at the Faculty of Pharmacy, Université de Montréal. He holds an affiliation with the GRUM—Groupe de recherche universitaire sur le médicament. His expertise focuses on drug formulation, regulatory compliance, and pharmaceutical quality assurance.
He teaches courses including PHM-6029 (Drug Chemistry and Manufacturing), PHM-6155 (Capstone Project), and SBP-2041 (Biopharmacy and Formulation). His research spans drug development, oncology therapeutics, and quality management systems in pharmaceutical industries.
- Current projects include developing MDM2 inhibitors for oncology (2023–2026), nicotine vaporizer regulations (2024–2025), and quality assurance digitization in generic pharmaceuticals (2023–2024).
- Funding sources include MITACS, CQDM, Saydi Biotech, and the Natural Sciences and Engineering Research Council of Canada (NSERC).
He collaborates on initiatives to optimize pharmaceutical production documentation and stability studies, emphasizing Kaizen methodologies and regulatory adherence.
۰مقاله منتشرشده
